N/A N=30 Diagnostic

Evaluation of a New Sonoclot Device for Heparin Management in Cardiac Surgery

Diagnostic Techniques and Procedures · Cardiac Surgical Procedure

Bottom Line

View on ClinicalTrials.gov: NCT02588976 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Apr 2018

Primary outcome: Primary: Kaolin-activated Clotting Time — 309 seconds

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Sonoclot Analyzer (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Triemli Hospital
Primary completion: Jan 2010

Outcome Measures

Outcome	Result	p-value
PRIMARY Kaolin-activated Clotting Time	309	—
SECONDARY Glass Bead Activated Clotting Time	195	—

Summary

The SONOCLOT Analyzer (S1; Sienco, Inc. Boulder, CO USA, Model DP-2951) is used to perform kaolin-based activated clotting time as routine monitor of heparin therapy in patients undergoing cardiac operations. In addition, the device allows the assessment of the patient's coagulation status by a glass-bead activated test. Recently, a new SONOCLOT analyzer (S2) has been developed. As part of the routine management using S1, tests are also performed on S2. Results are entered into the cardiac surgery data base of all cardiac surgery patients and analyzed.

Eligibility Criteria

Inclusion Criteria

all consecutive cardiac surgery patients

Exclusion Criteria

none

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02588976). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.